SHIN NIPPON BIOMEDICAL LABORATORIES LTD financial statements, including revenue, expenses, profit, and loss

The total revenue of YB3 for the last quarter is 51.84 M EUR, and it's 32.33% higher compared to the previous quarter. The net income of Q4 23 is 10.63 M EUR.